PATENT CLAIM ANALYSIS

Application Number: 16068933
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["514", "019300"]

Abstract:
The present invention provides compositions comprising Verteporfin and other anticancer compounds linked to a hydrophilic peptide through a degradable linker molecule to allow the anticancer compounds to penetrate tissues via in situ administration. The compounds of the present invention are useful for sensitizing tumor cells to radiotherapy, preventing recurrence of tumors after surgical resection and for treating remaining unremoved cancer cells at the site of the tumor.

Claim (Index 7):
The composition of  claim 6 , wherein T is RGDS (SEQ ID NO: 1).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12514622', '15161123', '15317559', '16012536', '14009327']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7120448404971272
- 35 USC 102 Novelty (BERT): 0.5140510540191284
- Combined Prediction Score: 0.6922454618493274
- Mean Citation Score: 141.60558600000005
- Max Citation Score: 145.88253999999995
- Similarity Product: 72.2042322377145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test